Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))

Jorge Cortes, Deborah Thomas, Charles Koller, Frances Giles, Elihu Estey, Stefan Faderl, Guillermo Garcia-Manero, David McConkey, Stacey L. Ruiz, Roberto Guerciolini, John Wright, Hagop Kantarjian

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume10
Issue number22
StatePublished - Dec 15 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cortes, J., Thomas, D., Koller, C., Giles, F., Estey, E., Faderl, S., Garcia-Manero, G., McConkey, D., Ruiz, S. L., Guerciolini, R., Wright, J., & Kantarjian, H. (2004). Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377)). Clinical Cancer Research, 10(22).